Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 2
1950 2
1951 2
1952 2
1953 1
1954 1
1955 2
1956 1
1958 3
1959 4
1960 9
1961 13
1962 9
1963 24
1964 24
1965 25
1966 32
1967 36
1968 50
1969 60
1970 31
1971 44
1972 61
1973 92
1974 68
1975 89
1976 80
1977 100
1978 66
1979 81
1980 68
1981 71
1982 91
1983 68
1984 82
1985 68
1986 92
1987 73
1988 73
1989 78
1990 95
1991 80
1992 103
1993 90
1994 128
1995 115
1996 119
1997 114
1998 164
1999 148
2000 165
2001 167
2002 226
2003 244
2004 198
2005 218
2006 180
2007 140
2008 146
2009 118
2010 120
2011 124
2012 103
2013 132
2014 118
2015 100
2016 96
2017 88
2018 87
2019 66
2020 64
2021 64
2022 56
2023 62
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

5,780 results

Results by year

Filters applied: . Clear all
Page 1
Bazedoxifene for HRT?
[No authors listed] [No authors listed] Drug Ther Bull. 2017 Apr;55(4):42-44. doi: 10.1136/dtb.2017.4.0466. Drug Ther Bull. 2017. PMID: 28408389 Review.
Duavive (Pfizer) is a modified-release formulation of conjugated oestrogens plus bazedoxifene acetate (a selective oestrogen receptor modulator). It is licensed for treatment of oestrogen deficiency symptoms in postmenopausal women with a uterus for whom treatment with pro …
Duavive (Pfizer) is a modified-release formulation of conjugated oestrogens plus bazedoxifene acetate (a selective oestrogen receptor …
To clot, or not to clot: The dilemma of hormone treatment options for menopause.
Booyens RM, Engelbrecht AM, Strauss L, Pretorius E. Booyens RM, et al. Thromb Res. 2022 Oct;218:99-111. doi: 10.1016/j.thromres.2022.08.016. Epub 2022 Aug 19. Thromb Res. 2022. PMID: 36030662 Review.
Many treatments are available to relieve these symptoms such as Conjugated Equine Estrogen and bioidentical hormones. The routes of administration include oral and transdermal. ...
Many treatments are available to relieve these symptoms such as Conjugated Equine Estrogen and bioidentical hormones. The routes of a …
Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action.
Bhavnani BR, Stanczyk FZ. Bhavnani BR, et al. J Steroid Biochem Mol Biol. 2014 Jul;142:16-29. doi: 10.1016/j.jsbmb.2013.10.011. Epub 2013 Oct 28. J Steroid Biochem Mol Biol. 2014. PMID: 24176763 Review.
Oral conjugated equine estrogens (CEE) are the most used estrogen formulation for postmenopausal hormone therapy either alone or in combination with a progestin. ...The product monogram lists the presence of only 10 estrogens consisting of the classical es …
Oral conjugated equine estrogens (CEE) are the most used estrogen formulation for postmenopausal hormone therapy either alone …
Co-Opting Host Receptors for Targeted Delivery of Bioconjugates-From Drugs to Bugs.
Tummillo KM, Hazlett KRO. Tummillo KM, et al. Molecules. 2021 Mar 9;26(5):1479. doi: 10.3390/molecules26051479. Molecules. 2021. PMID: 33803208 Free PMC article. Review.
This assembly can result in the production of constructs that are targeted to a specific site or cell type in order to enhance the response to, or activity of, the conjugated moiety. In the case of cancer treatments, selectively targeting chemotherapies to the cells of int …
This assembly can result in the production of constructs that are targeted to a specific site or cell type in order to enhance the response …
Estrogen dose: the cardiovascular impact.
Panay N. Panay N. Climacteric. 2009;12 Suppl 1:91-5. doi: 10.1080/13697130903008288. Climacteric. 2009. PMID: 19811250 Review.
There are a number of possible reasons but, in the opinion of the author, the dose of estrogen was the overriding factor. Although 0.625 mg of conjugated equine estrogens is a standard dose for women in their early fifties, this was a relative overdose for women wit …
There are a number of possible reasons but, in the opinion of the author, the dose of estrogen was the overriding factor. Although 0.625 mg …
Complex and simple.
Lansky EP, Von Hoff DD. Lansky EP, et al. Leuk Res. 2005 Jun;29(6):601-2. doi: 10.1016/j.leukres.2004.12.012. Epub 2005 Feb 26. Leuk Res. 2005. PMID: 15863195 No abstract available.
Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
Sharifi M, Lewiecki EM. Sharifi M, et al. Expert Rev Clin Pharmacol. 2014 May;7(3):281-91. doi: 10.1586/17512433.2014.893819. Epub 2014 Mar 3. Expert Rev Clin Pharmacol. 2014. PMID: 24580081 Review.
Menopausal therapy with a tissue selective estrogen complex combines estrogens with a selective estrogen receptor modulator, with the goal of blending the desirable effects of estrogens on menopausal symptoms and bone with the tissue selective properties of a select …
Menopausal therapy with a tissue selective estrogen complex combines estrogens with a selective estrogen receptor modulator, with the …
Risks of estrogens and progestogens.
L'Hermite M. L'Hermite M. Maturitas. 1990 Sep;12(3):215-46. doi: 10.1016/0378-5122(90)90005-q. Maturitas. 1990. PMID: 2170823 Review.
Both ethinyl estradiol and equine estrogens may increase blood pressure, while natural estrogens may decrease it. Similarly natural estrogens induce prostacyclin synthesis, while ethinyl estradiol activates both prostacyclin and thromboxanes. ...
Both ethinyl estradiol and equine estrogens may increase blood pressure, while natural estrogens may decrease it. Similarly na …
Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.
Bhavnani BR. Bhavnani BR. Proc Soc Exp Biol Med. 1998 Jan;217(1):6-16. doi: 10.3181/00379727-217-44199. Proc Soc Exp Biol Med. 1998. PMID: 9421201 Review.
Conjugated equine estrogens (Premarin), are used extensively for estrogen replacement therapy and prevention of osteoporosis and cardiovascular disease in postmenopausal women. ...The pharmacokinetics of these estrogens indicate that the unconjugated estro …
Conjugated equine estrogens (Premarin), are used extensively for estrogen replacement therapy and prevention of osteoporosis a …
5,780 results